News

Events

ELITechGroup SYMPOSIUM

Monday 24th April 2017 (Vienna – Austria) ELITechGroup Symposium (Molecular Diagnostics) : ELITe InGenius® the highly flexible sample-to-result solution  (program) ELITechGroup Symposim (Microbiology) : Introducing the Rapid Polymyxin… See Details

See Us at the SCACM Spring Meeting on March 23, 2017

EliTechGroup will be exhibiting at the South Central Association for Clinical Microbiology (SCACM) Spring Meeting, held from Thursday, March 23 to Saturday, March 25, 2017…. See Details

SAVE THE DATE – ELITechGroup Macroduct User Group Meeting – Melbourne

Click here to read more : Macroduct UGM For further information, please contact: Australia- Ph: 1800 815 098 Email: elitechaustralia@elitechgroup.com New Zealand- Ph: 0800 555 611… See Details


Press Releases

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the Meningitis Viral 2 ELITe MGB® Panel for the detection of Enterovirus, Parechovirus, and Adenovirus with ELITe InGenius®

Puteaux, France, 6th July 2017 – ELITechGroup Molecular Diagnostics, announces today the launch of a high-performance real-time PCR assay: Meningitis Viral 2 ELITe MGB® Panel… See Details

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of… See Details

ELITechGroup Molecular Diagnostics announced the CE-IVD marking of the Coagulation ELITe MGB® Kit, a multiplex assay for the detection of Factor V, Factor II, and MTHFR genetic variants

Puteaux, France, 27th January 2017 – ELITechGroup Molecular Diagnostics announced today the CE-IVD marking of the Coagulation ELITe MGB® Kit, a high-performance, multiplex assay for… See Details

ELITechGroup receives FDA Emergency Use Authorization for Zika ELITe MGB® Kit U.S. performedusing the ELITe InGenius™ instrument

ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB® Kit U.S…. See Details

ELITechGroup Announces Agreement with Abbott to Expand Distribution Channels

Puteaux, France November 9th, 2016 – ELITechGroup today announced a U.S. distribution agreement, with Abbott’s Molecular business, for molecular diagnostic reagents. The reagents target a… See Details

ELITechGroup Molecular Diagnostics announce the CE-IVD marking of the CRE ELITe MGB® Kit, for the detection of the Carbapenem Resistance genes of Enterobacteriaceae

Puteaux, France November 8th, 2016 – ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® kit, a high-performance, qualitative, multiplex assay… See Details

NEW – Press release – Rapid Detection of Resistance to Polymyxins

Signes, France – October 17th, 2016 – Among the most clinically significant multidrug-resistant bacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usually remain susceptible to polymyxins,… See Details


Product News

Leukemia: Cancer Cells Killed By Diabetes Drug

Leukemia: Cancer Cells Killed By Diabetes Drug

This year in North America, it was estimated that more than 21,000 people would be diagnosed with acute myeloid leukemia. And unfortunately, about 50 percent… See Details

Smartphones Are Versatile Diagnostic Tools

Smartphones Are Versatile Diagnostic Tools

Smartphones have become increasingly popular and nearly ubiquitous in developed regions, since Apple’s iPhone was first introduced ten years ago in 2007. Nearly half of… See Details

New Heart Failure Treatment Possibility

The number of people suffering from heart failure is expected to increase almost 50 percent over the course of the next 15 years. This is… See Details

Medical Drones Will Take Off

In 1925, a group of mushers transported a critical batch of diphtheria antitoxin by dog sled to the Alaskan town of Nome to treat a… See Details

Microchip Technology May Track Smart Pills

Medical technology continues to improve at breathtaking speeds. The latest medical microchip technology breakthrough continues that trend. Researchers have now developed a new miniature medical… See Details

New Cancer Treatment Re-Engineers Human Cells

Cancer treatment has historically involved a combination of surgery, chemotherapy, and radiation treatment. While treatment options have evolved considerably over time, the same general approach… See Details

Newest Lyme Disease Test

Lyme disease is a growing concern in many areas of the U.S. and Europe. First identified in 1975, the disease now affects 300,000 people per… See Details

Healthcare Predictions 2018

Healthcare is a rapidly growing field that accounts for a significant percentage of annual spending in many countries. According to the World Health Organization, global… See Details

New Advancement in Cystic Fibrosis

Cystic fibrosis is a genetic disease that affects more than 70,000 people worldwide, with another 1,000 diagnosed with the disease each year. There are more… See Details

Despite advances in the treatment and survival rates for many forms of cancer, glioblastoma has remained difficult to treat.

New Research Regarding Glioma Stem Cells

Despite advances in the treatment and survival rates for many forms of cancer, glioblastoma has remained difficult to treat. Long-term survival rates for patients afflicted… See Details